FDA/USP meeting on Treatment INDs
Executive Summary
On May 3, FDA Associate Commissioner for Health Affairs Stuart Nightingale, MD, met with U.S. Pharmacopeial Executive Director Jerome Halperin and two members of the USP Board of Trustees to discuss how USP can help FDA to announce the availability of and information on Treatment IND drugs. USP agreed to publish the information in a new index to volume one of the USP DI, information compendium that goes to pharmacists, physicians and hospitals.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.